Veterinary Medicines

Nobilis IBmulti + G + ND

Authorised
  • Infectious bursal disease virus, strain D78, Inactivated
  • Avian infectious bronchitis virus, strain D274, Inactivated
  • Avian infectious bronchitis virus, type Massachusetts, strain M41, Inactivated
  • Newcastle disease virus, strain Clone 30, Inactivated
Download as PDF

Product identification

Medicine name:
Nobilis IBmulti + G + ND
Active substance:
  • Infectious bursal disease virus, strain D78, Inactivated
  • Avian infectious bronchitis virus, strain D274, Inactivated
  • Avian infectious bronchitis virus, type Massachusetts, strain M41, Inactivated
  • Newcastle disease virus, strain Clone 30, Inactivated
Target species:
  • Chicken
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Infectious bursal disease virus, strain D78, Inactivated
    23170.40
    unit(s)
    /
    1.00
    Dose
  • Avian infectious bronchitis virus, strain D274, Inactivated
    16.00
    unit(s)
    /
    1.00
    Dose
  • Avian infectious bronchitis virus, type Massachusetts, strain M41, Inactivated
    45.20
    unit(s)
    /
    1.00
    Dose
  • Newcastle disease virus, strain Clone 30, Inactivated
    50.00
    unit(s)
    /
    1.00
    Dose
Pharmaceutical form:
  • Emulsion for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Chicken
      • Meat and offal
        no withdrawal period
      • Egg
        no withdrawal period
  • Subcutaneous use
    • Chicken
      • Meat and offal
        no withdrawal period
      • Egg
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AA08
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Netherlands
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Intervet Nederland B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • INTERVET INTERNATIONAL B.V.
Responsible authority:
  • Medicines Evaluation Board
Authorisation number:
  • REG NL 7476
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 23/02/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."